Recently, Beijing Tsingying Huakang Technology Co., Ltd. or Tsimaging Technology completed its Pre-A round of equity financing worth tens of millions of yuan, led by BOHE Angel Fund and jointly invested by TusStar Ventures.
As a scientific and technological achievement transformation enterprise by the Biomedical Imaging Research Center of Tsinghua University, Tsimaging Technology is committed to providing advanced medical solutions to help doctors serve patients with precise imaging diagnostic methods.
To fulfill this commitment, Tsimaging Technology has launched a high-resolution magnetic resonance tube wall imaging solution.
Currently, Tsimaging Technology has developed hundreds of hospital customers, including various first-tier public hospitals like Beijing Hospital, Tiantan Hospital, Chinese PLA General Hospital, Shanghai Renji Hospital, Nanjing Drum Tower Hospital, and Fujian Medical University Union Hospital, covering more than 20 provinces across the country.
What’s more, Tsimaging Technology has also carried out extensive cooperation with major MRI manufacturers, including Philips, Siemens, GE, United Imaging and Chinese medical cloud platforms, third-party imaging centers and other institutions.
Li Rui, founder of Tsimaging Technology and Chief Scientist of the Biomedical Imaging Research Center of Tsinghua University, said that Tsimaging Technology plans to transform medical imaging results in research institutions and combine them with a wide range of domestic medical resources in the future; thus providing advanced imaging solutions for major human diseases.
Li Rui believes that the introduction of such solutions would greatly enhance the application level of medical imaging in China.